Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TPEX/4911 stock hub

TPEX/4911 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/4911is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.2B

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/4911

In the news

Latest news · TPEX/4911

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/E15.7

P25 14.4P50 18P75 31.9

ROE15.8

P25 -16.2P50 0.3P75 9.8

ROIC27.1

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/4911 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

232

Groups with data

Currency

TWD

Showing 232 of 232 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees	39
Employees Change	2%
Employees Change Percent	5.41
Enterprise value	TWD 1.8B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Biotechnology
Isin	TW0004911003
Last refreshed	2026-05-10
Market cap	TWD 2.2B
Price	TWD 34.3
Price currency	TWD
Rev Per Employee	7,926,461.54x
Sector	Healthcare
Sic	2834
Symbol	tpex/4911
Website	https://www.geherbs.com.tw

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.37%
EV Earnings	12.62x
EV/EBIT	11.53x
EV/EBITDA	10.78x
EV/FCF	26.22x
EV/Sales	5.68x
FCF yield	3.06%
P/B ratio	2.35x
P/E ratio	15.73x
P/S ratio	7.07x
PE Ratio3 Y	46.59x
PE Ratio5 Y	73.98x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	49.27%
EBITDA Margin	52.41%
FCF margin	21.67%
Gross margin	85.15%
Gross Profit	TWD 263.2M
Gross Profit Growth	28.18%
Gross Profit Growth Q	-2.98%
Gross Profit Growth3 Y	88.41%
Gross Profit Growth5 Y	85.41%
Net Income	TWD 139.2M
Net Income Growth	36.38%
Net Income Growth Q	-12.49%
Net Income Growth Years	4%
Net Income Growth3 Y	166.18%
Pretax Margin	51.24%
Profit Margin	45.03%
Profit Per Employee	TWD 3.6M
Profitable Years	4
ROA	9.84
Roa5y	4.55
ROCE	16.41
ROE	15.8
Roe5y	7.35
ROIC	27.07
Roic5y	12.53

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-9.85%
Cagr15y	-2.74%
Cagr1y	-29.9%
Cagr3y	-19.69%
Cagr5y	7%
Div CAGR3	12.73%
Div CAGR5	7.45%
EPS Growth	36.25
EPS Growth Q	-12.43
EPS Growth Years	4
EPS Growth3 Y	167.7
FCF Growth	-47.98%
FCF Growth Q	-83.8%
FCF Growth3 Y	-11.62%
OCF Growth	-47.89%
OCF Growth Q	-83.92%
OCF Growth3 Y	-11.12%
OCF Growth5 Y	146.51%
Revenue Growth	24.13x
Revenue Growth Q	-3.69x
Revenue Growth Years	4x
Revenue Growth3 Y	68.51x
Revenue Growth5 Y	61.39x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.32
Assets	TWD 975.2M
Cash	TWD 430.3M
Current Assets	TWD 474.7M
Current Liabilities	TWD 47.1M
Debt	TWD 869,000
Debt EBITDA	TWD 0.01
Debt Equity	TWD 0
Debt FCF	TWD 0.01
Equity	TWD 928.1M
Interest Coverage	5,251.8
Liabilities	TWD 47.1M
Long Term Assets	TWD 500.5M
Long Term Liabilities	TWD 93,000
Net Cash	TWD 429.4M
Net Cash By Market Cap	TWD 19.65
Net Cash Growth	5.48%
Net Debt EBITDA	TWD -2.65
Net Debt Equity	TWD -0.46
Net Debt FCF	TWD -6.41
Tangible Book Value	TWD 795.3M
Tangible Book Value Per Share	TWD 12.48
WACC	0.73

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	10.09
Inventory Turnover	1.95
Net Working Capital	TWD -1.9M
Quick ratio	9.51
Working Capital	TWD 427.6M
Working Capital Turnover	TWD 0.82

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.08%
Dividend Growth	43.24%
Dividend Growth Years	3%
Dividend per share	TWD 1.17
Dividend Years	2
Dividend Yield	3.4%
Ex Div Date	2025-07-29
Last Dividend	TWD 0.76
Payout Frequency	Annual
Payout Ratio	32.08%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-64.54%
1Y total return	-29.88%
200-day SMA	44.58
3Y total return	-48.2%
50-day SMA	35.94
50-day SMA vs 200-day SMA	50under200
5Y total return	40.23%
All Time High	160.5
All Time High Change	-78.64%
All Time High Date	2009-10-06
All Time Low	18.69
All Time Low Change	83.49%
All Time Low Date	2020-03-23
ATR	1.06
Beta	-0.64
Beta1y	-0.15
Beta2y	0.17
Ch YTD	-20.05
High	35
High52	56.6
High52 Date	2025-09-02
High52ch	-39.4%
Low	34.3
Low52	33
Low52 Date	2026-03-06
Low52ch	3.94%
Ma50ch	-4.56%
Price vs 200-day SMA	-23.06%
RSI	39.6
RSI Monthly	32.05
RSI Weekly	27.57
Sharpe ratio	-1.16x
Sortino ratio	-1.59
Total Return	3.32%
Tr YTD	-20.05
Tr15y	-34.09%
Tr1m	-15.31%
Tr1w	0.59%
Tr3m	-16.34%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD 152.3M
Operating Income Growth	27.29
Operating Income Growth Q	-15.22
Operating Income Growth3 Y	202.8
Operating margin	49.27

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	47,586,281%
Net Borrowing	-877,000
Shares Insiders	25.32%
Shares Out	63,719,568
Shares Qo Q	0.27%
Shares Yo Y	0.08%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD 67M
Average Volume	41,721.95x
Bv Per Share	14.56
CAPEX	TWD -3.2M
Ch10y	-65.4
Ch15y	-35.8
Ch1m	-15.31
Ch1w	0.59
Ch1y	-30.89
Ch3m	-16.34
Ch3y	-49.46
Ch5y	36.82
Ch6m	-30
Change	-2%
Change From Open	-2
Close	35
Days Gap	0
Depreciation Amortization	9,727,000
Dollar Volume	553,053.2
Earnings Date	2026-08-27
EBIT	TWD 152.3M
EBITDA	TWD 162M
EPS	TWD 2.18
F Score	6
FCF	TWD 67M
FCF EV Yield	3.81x
FCF Per Share	TWD 1.05
Financing CF	-45,534,000
Fiscal Year End	December
Founded	2,002
Graham Number	26.7284
Graham Upside	-22.07
Income Tax	TWD 19.2M
Investing CF	-98,815,000
Is Primary Listing	1
Last Earnings Date	2025-11-07
Last Report Date	2025-12-31
Last Split Date	2025-07-29
Last Split Type	Forward
Lynch Fair Value	TWD 54.5
Lynch Upside	58.89
Ma150	42.74
Ma150ch	-19.74%
Ma20	35.79
Ma20ch	-4.16%
Net CF	-74,172,000
Next Earnings Date	2026-08-27
Open	35
P FCF Ratio	32.63
P OCF Ratio	31.14
Payment Date	2025-08-21
Position In Range	0
Ppne	366,035,000
Price Date	2026-05-08
Price EBITDA	TWD 13.49
Ptbv Ratio	2.75
Relative Volume	0.38x
Revenue	309,132,000x
Tax By Revenue	6.21x
Tax Rate	12.12%
Tr6m	-30%
Volume	16,124
Z Score	41.23

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TPEX/4911 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.4%

$1.17 annual per share

Payout ratio

+32.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+7.5%

3 consecutive years of growth

Total shareholder yield

+3.3%

Next ex-dividend date: 2025-07-29

Performance

TPEX/4911 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/4911?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+25.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.1%

Negative means the company is buying back shares.

Technical

TPEX/4911 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

39.6

Neutral momentum band

Price vs 200-day MA

-23.1%

50/200-day relationship not available

Beta (5Y)

-0.64

Less volatile than the market

Sharpe ratio

-1.16

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/4911

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/4911 stock rating?

tpex/4911 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/4911 analysis?

The full report lives at /stocks/tpex/4911/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/4911?

The latest report frames tpex/4911 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/4911 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.